A revolution of hope.. The start of the largest global trial for early detection of cancer

0
18


In a very good news and a step that may constitute a scientific revolution in the world of medicine, the National Health Authority of the state in Britain will start Monday the largest experiment in the world to test the main gallery blood produced by the Grill Company, which can be used to detect more than 50 types of cancer before symptoms appear.

It is noteworthy that the Gallery test examines the DNA in the patient’s blood to determine whether the source of any of it is cancerous cells. Early diagnosis of cancer increases cure rates dramatically.

The NHS said it wanted 140,000 volunteers in England to see how well the test worked as part of a randomized control trial. The blood samples of half of the participants will be immediately examined by the Gallery test, according to Reuters.

‘Massive change’

As Peter Sasini, Professor of Cancer Prevention at King’s College London, explained: “We need to study the Gallery test carefully to see if it significantly reduces the number of late-stage cancers.

“The test can make a huge difference to the early detection of cancer and we are excited to be the pioneers in this important research,” Sasini added.

Most common death

Lung cancer is by far the most common cause of cancer death in the UK, accounting for one fifth of all cancer deaths. The NHS said lung, bowel, prostate and breast cancer were responsible for 45% of all deaths from cancer in the UK.

It is noteworthy that the American company Illumina announced last month that it had completed the acquisition of Grill in a deal worth $7.1 billion. Illumina said it will operate Grill separately from its current company.

");
//},3000);
}
});
//$(window).bind('scroll');
$(window).scroll(function () {
if (alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true;
// $(window).unbind('scroll');
// console.log(" scroll loaded");

(function (d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.async = true;
js._https = true;
js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
fjs.parentNode.insertBefore(js, fjs);
}(document, 'script', 'facebook-jssdk'));
// pre_loader();
// $(window).unbind('mousemove');
//setTimeout(function(){
// $('#boxTwitter').html("");
//},3000);

var scriptTag = document.createElement("script");
scriptTag.type = "text/javascript"
scriptTag.src = "https://news.google.com/scripts/social.js";
scriptTag.async = true;
document.getElementsByTagName("head")[0].appendChild(scriptTag);

(function () {
$.getScript("https://news.google.com/scripts/social.js", function () { });
});

}
});

//$(window).load(function () {
// setTimeout(function(){
// // add the returned content to a newly created script tag
// var se = document.createElement('script');
// se.type = "text/javascript";
// //se.async = true;
// se.text = "setTimeout(function(){ pre_loader(); },5000); ";
// document.getElementsByTagName('body')[0].appendChild(se);
// },5000);
//});





LEAVE A REPLY

Please enter your comment!
Please enter your name here